JAZZ vs MLKN · P/E 1988, rev $4.07B vs P/E 15, rev $3.67B
Jazz Pharmaceuticals PLC (JAZZ) versus MillerKnoll Inc (MLKN) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
MillerKnoll Inc (MLKN) is a furnishings, fixtures & appliances company listed on US.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported MLKN revenue for 2025-05-31 was $3.67B. Net income was -$33.2M. Revenue was up 1.1% from 2024-06-01 to 2025-05-31. MLKN currently screens at market cap $1.39B and trailing P/E 15.5.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. MLKN currently screens at market cap $1.39B and trailing P/E 15.5.
Not investment advice. Open the JAZZ and MLKN stock pages for the full models.
Not investment advice.